Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xanthine is a naturally occurring purine base (C5H4N4O2) found in most body tissues and fluids as an intermediate in purine metabolism, specifically during the degradation of adenosine monophosphate to uric acid[1][4][5]. While chemically related methylxanthines (such as caffeine and theophylline) are important pharmaceutical agents, xanthine itself is not considered a direct therapeutic target, enzyme, or receptor, but rather a small molecule metabolite and parent compound for pharmacologically active derivatives[5][6]. High serum xanthine concentrations can lead to the formation of xanthine kidney stones, and hereditary enzyme deficiencies in xanthine metabolism can result in clinical disorders[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xanthine.